Stay updated with breaking news from Ro Eb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Adria Calatayud Roche Holding is scheduled to report results for 2023 on Thursday. Here is what you need to know. SALES FORECAST: The Swiss pharmaceutical...
By Andrea Figueras Roche said it obtained positive results for its investigational treatment, inavolisib, as a first-line treatment for people with breast...
By Andrea Figueras Roche said that it has received positive long-term follow-up data and significant overall survival benefit from the Katherine study, which...
By Helena Smolak Shares of Germany's Merck KGaA plunged after its experimental drug evobrutinib failed in two late-stage trials of patients with relapsing...
By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The...